Suppr超能文献

评估由药剂师-营养师主导的以患者为中心的慢性肾脏病-矿物质和骨异常管理方法:一项混合方法研究。

Evaluation of a Pharmacist-Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study.

作者信息

Baker Tamara, Naylor Heather, MacNeil Bryanne, MacKinnon Martin

机构信息

Department of Pharmacy, Nova Scotia Health Authority (Central Zone), QEII Health Sciences Centre, Halifax, NS B3K 4N1, Canada.

Department of Pharmacy, Horizon Health Network, Saint John Regional Hospital, Saint John, NB E2L 4L4, Canada.

出版信息

Pharmacy (Basel). 2020 Sep 14;8(3):171. doi: 10.3390/pharmacy8030171.

Abstract

Chronic kidney disease mineral and bone disorder (CKD-MBD) is a common complication in end-stage renal disease (ESRD). To improve prescribing consistency and patient outcomes, a patient-centered, pharmacist-dietician-led approach to managing CKD-MBD was developed. The purpose of this study was to evaluate if the new approach impacted serum markers of CKD-MBD and medication burden, and to evaluate patient satisfaction. A single-arm, pre-post, mixed-methods study was conducted. Serum markers of CKD-MBD and medication data were collected pre- and post-intervention, and a patient survey administered post-intervention. Focus groups were conducted, transcribed, and analyzed thematically. No statistically significant differences in serum markers of CKD-MBD or medication burden were found. Eighty-seven percent of patients were satisfied with their care, however, 31% were very dissatisfied with medical explanations provided to them and 48% felt their allotted time with healthcare professionals was too short. Four major themes identified from focus groups included lack of privacy, knowledge and perceptions of blood work rounds, issues with taking phosphate binders, and areas for increased patient education. Patients would prefer more information regarding their blood work results and more time with the healthcare team. Areas for expanded education include renal diet, phosphate binders, and consequences of abnormal bloodwork.

摘要

慢性肾脏病矿物质和骨异常(CKD-MBD)是终末期肾病(ESRD)的常见并发症。为提高处方的一致性和患者治疗效果,制定了一种以患者为中心、由药剂师-营养师主导的CKD-MBD管理方法。本研究的目的是评估这种新方法是否会影响CKD-MBD的血清标志物和药物负担,并评估患者满意度。开展了一项单组前后对照的混合方法研究。在干预前后收集CKD-MBD的血清标志物和用药数据,并在干预后进行患者调查。进行了焦点小组讨论,对讨论内容进行转录并进行主题分析。未发现CKD-MBD血清标志物或药物负担有统计学显著差异。87%的患者对其治疗感到满意,然而,31%的患者对提供给他们的医学解释非常不满意,48%的患者觉得他们与医护人员的预约时间太短。焦点小组确定的四个主要主题包括缺乏隐私、对血液检查查房的了解和认知、服用磷结合剂的问题以及加强患者教育的领域。患者希望获得更多有关其血液检查结果的信息,并希望有更多时间与医护团队交流。需要扩大教育的领域包括肾脏饮食、磷结合剂以及血液检查异常的后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c0/7559797/acfce5314300/pharmacy-08-00171-g0A1.jpg

相似文献

2
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice.
Nephrol Dial Transplant. 2011 Apr;26(4):1319-26. doi: 10.1093/ndt/gfq602. Epub 2010 Oct 8.
5
Fracture risk in chronic kidney disease: A Korean population-based cohort study.
Kidney Res Clin Pract. 2019 Jun 30;38(2):220-228. doi: 10.23876/j.krcp.18.0099.
6
Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
Am J Kidney Dis. 2014 Nov;64(5):770-80. doi: 10.1053/j.ajkd.2014.04.014. Epub 2014 May 13.
7
Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
J Nephrol. 2016 Feb;29(1):71-8. doi: 10.1007/s40620-015-0202-4. Epub 2015 May 19.
8
Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Int J Mol Sci. 2020 Sep 18;21(18):6846. doi: 10.3390/ijms21186846.
9
Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Nephrol Dial Transplant. 2014 Oct;29(10):1815-20. doi: 10.1093/ndt/gft514. Epub 2014 Feb 9.
10
Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
Adv Chronic Kidney Dis. 2011 Mar;18(2):120-31. doi: 10.1053/j.ackd.2011.02.004.

引用本文的文献

1
Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: A cross-sectional study.
Front Med (Lausanne). 2023 Apr 14;10:1142013. doi: 10.3389/fmed.2023.1142013. eCollection 2023.

本文引用的文献

2
Hyperphosphatemia Management in Patients with Chronic Kidney Disease.
Saudi Pharm J. 2016 Jul;24(4):494-505. doi: 10.1016/j.jsps.2015.01.009. Epub 2015 Jan 12.
3
A Thematic Synthesis of the Experiences of Adults Living with Hemodialysis.
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1206-1218. doi: 10.2215/CJN.10561015. Epub 2016 May 31.
4
Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.
Nephrol Dial Transplant. 2016 Mar;31(3):368-75. doi: 10.1093/ndt/gfv003. Epub 2015 Jan 29.
6
What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs.
Health Aff (Millwood). 2013 Feb;32(2):207-14. doi: 10.1377/hlthaff.2012.1061.
8
Association of serum phosphate with vascular and valvular calcification in moderate CKD.
J Am Soc Nephrol. 2009 Feb;20(2):381-7. doi: 10.1681/ASN.2008040349. Epub 2008 Dec 10.
9
Improving global outcomes in mineral and bone disorders.
Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3(Suppl 3):S127-30. doi: 10.2215/CJN.04331206.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验